Giuseppe Legname

Prof. Dr. Giuseppe Legname

Scuola Internazionale Superiore di Studi Avanzati, Trieste, Italy
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2004 in Science
Verified
Journal Article
Closed access
PDF file
Giuseppe LegnameGiuseppe Legname
Giuseppe Legname
IBIlia V. Baskakov
Ilia V. Baskakov
HNHoang-Oanh B. Nguyen
Hoang-Oanh B. Nguyen
DRDetlev Riesner
Detlev Riesner
FCFred E. Cohen
Fred E. Cohen
SPStanley B. Prusiner
Stanley B. Prusiner
Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of β sheet–rich structures. Fibrils consisting of recMoPrP(89–230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89–231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are infectious proteins.

16 August 2001 in Nature
Verified
Journal Article
Closed access
PDF file
DPDavid Peretz
David Peretz
RWR. Anthony Williamson
R. Anthony Williamson
KKKiotoshi Kaneko
Kiotoshi Kaneko
JVJulie Vergara
Julie Vergara
ELEstelle Leclerc
Estelle Leclerc
SPStanley B. Prusiner
Stanley B. Prusiner

1 June 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
IBIlia V. Baskakov
Ilia V. Baskakov
Giuseppe LegnameGiuseppe Legname
Giuseppe Legname
MBMichael A. Baldwin
Michael A. Baldwin
SPStanley B. Prusiner
Stanley B. Prusiner
FCFred E. Cohen
Fred E. Cohen
In vivo under pathological conditions, the normal cellular form of the prion protein, PrPC (residues 23–231), misfolds to the pathogenic isoform PrPSc, a β-rich aggregated pathogenic multimer. Proteinase K digestion of PrPSc leads to a proteolytically resistant core, PrP 27–30 (residues 90–231), that can form amyloid fibrils. To study the kinetic pathways of amyloid formation in vitro, we used unglycosylated recombinant PrP corresponding to the proteinase K-resistant core of PrPSc and found that it can adopt two non-native abnormal isoforms, a β-oligomer and an amyloid fibril. Several lines of kinetic data suggest that the β-oligomer is not on the pathway to amyloid formation. The preferences for forming either a β-oligomer or amyloid can be dictated by experimental conditions, with acidic pH similar to that seen in endocytic vesicles favoring the β-oligomer and neutral pH favoring amyloid. Although both abnormal isoforms have high β-sheet content and bind 1-anilinonaphthalene-8-sulfonate, they are dissimilar structurally. Multiple pathways of misfolding and the formation of distinct β-sheet-rich abnormal isoforms may explain the difficulties in refolding PrPSc in vitro, the need for a PrPSc template, and the significant variation in disease presentation and neuropathology.

1 December 2001 in Journal of Molecular Biology
Verified
Journal Article
Closed access
GSGerold Schmitt-Ulms
Gerold Schmitt-Ulms
Giuseppe LegnameGiuseppe Legname
Giuseppe Legname
MBMichael A Baldwin
Michael A Baldwin
HBHaydn L Ball
Haydn L Ball
NBNicole Bradon
Nicole Bradon
SPStanley B Prusiner
Stanley B Prusiner

13 December 2013 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PJP Joshi
P Joshi
ETE Turola
E Turola
AMAna Ruiz Moreno
Ana Ruiz Moreno
ABA Bergami
A Bergami
DLD D Libera
D D Libera
CFChiara Fenoglio
Chiara Fenoglio

15 May 2003 in Biochemistry
Verified
Journal Article
Closed access
CBColin S. Burns
Colin S. Burns
EAEliah Aronoff-Spencer
Eliah Aronoff-Spencer
Giuseppe LegnameGiuseppe Legname
Giuseppe Legname
SPStanley B. Prusiner
Stanley B. Prusiner
WAWilliam E. Antholine
William E. Antholine
GMGlenn L. Millhauser
Glenn L. Millhauser